Financhill
Back

Viatris Quote, Financials, Valuation and Earnings

Viatris Price Quote

$12.5200
-0.0100 (3.22%)
(Updated: December 21, 2024 at 5:53 AM ET)

Viatris Key Stats

Sell
49
Viatris (VTRS) is a Sell

Day range:
$12.1400 - $12.5650
52-week range:
$9.9250 - $13.6175
Dividend yield:
3.83%
P/E ratio:
250.60
P/S ratio:
1.00
P/B ratio:
0.76%

Volume:
55.1M
Avg. volume:
9.2M
1-year change:
19.9%
Market cap:
$15B
Revenue:
$15.4B
EPS:
$-0.74

How Much Does Viatris Make?

Data Unavailable

Is Viatris Growing As A Company?

Data Unavailable

Viatris Stock Price Performance

  • Did Viatris Stock Go Up Last Month?
    Viatris share price went down by -4.57% last month
  • Did VTRS's Share Price Rise Over The Last Year?
    VTRS share price rose by 19.9% over the past 1 year

What Is Viatris 52-Week High & Low?

  • What Is Viatris’s 52-Week High Share Price?
    Viatris has traded as high as $13.6175 over the past 52 weeks
  • What Is Viatris’s 52-Week Low Share Price?
    Viatris has traded as low as $9.9250 over the past 52 weeks

Viatris Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Viatris?

Data Unavailable

Is Viatris Cash Flow Positive?

Data Unavailable

Viatris Return On Invested Capital

Data Unavailable

Viatris Earnings Date & Stock Price

  • What Is Viatris's Stock Price Today?
    A single share of VTRS can be purchased today for 12.5300
  • What Is Viatris’s Stock Symbol?
    Viatris trades on the nasdaq under the ticker symbol: VTRS
  • When Is Viatris’s Next Earnings Date?
    The next quarterly earnings date for Viatris is scheduled on February 28, 2025
  • When Is VTRS's next ex-dividend date?
    Viatris's next ex-dividend date is November 22, 2024
  • How To Buy Viatris Stock?
    You can buy Viatris shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Viatris Competitors

  • Who Are Viatris's Competitors?
    Below is a list of companies who compete with Viatris or are related in some way:
    • Baxter International Inc (BAX)
    • Perspective Therapeutics Inc (CATX)
    • Gilead Sciences Inc (GILD)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • Moderna Inc (MRNA)

Viatris Dividend Yield

Data Unavailable

Viatris Analyst Estimates

YoY Growth Past Surprise
EPS: -70.37% 10.73%
Revenue: -4.84% 1.06%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 0.0000
Downside from Last Price: -100%

Major Shareholders

Data Unavailable